Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
PDD Holdings to Report First Quarter 2024 Unaudited Financial Results on May 22, 2024
May 15, 2024 07:30 ET
|
PDD Holdings Inc.
DUBLIN and SHANGHAI, May 15, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it will report its unaudited financial results for the...
VEON Publishes Annual Corporate Governance Report for Financial Year 2023
May 15, 2024 07:30 ET
|
VEON Ltd.
VEON Publishes Annual Corporate Governance Report for Financial Year 2023 Amsterdam, 15 May 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides...
Aspira Women’s Health Reports First Quarter 2024 Financial Results
May 15, 2024 07:30 ET
|
Aspira Women's Health Inc.
Q1 2024 OvaSuiteSM revenue of $2.2 million and volume of 5,829 units Q1 2024 cash utilization of $4.4 million, a decrease of 22% compared to Q1 2023 Conference Call and Webcast scheduled for today...
AppTech Payments Corp. Reports Strong Start to 2024 with Positive First Quarter Financial Results and Strategic Business Advances
May 15, 2024 07:30 ET
|
AppTech Corp.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, today announced its financial results for the first...
LeddarTech Reports F2Q24 Results
May 15, 2024 07:30 ET
|
LeddarTech inc.
LeddarTech Reports F2Q24 Results
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
May 15, 2024 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten at the European Society of Cardiology...
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
May 15, 2024 07:30 ET
|
Abeona Therapeutics Inc.
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into 2026 CLEVELAND, May 15, 2024 (GLOBE NEWSWIRE) -- Abeona...
Nayax Reports First Quarter 2024 Financial Results
May 15, 2024 07:30 ET
|
Nayax Ltd.
Strong first quarter with recurring revenue up 43% YoY; Total revenue of $64 million; Adjusted EBITDA of $3.6 million (1); Improving profitability with gross margins reaching 43.8% ...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 15, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and...